Recombinant Human IL-5RA protein (rFc Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
3568
Accession
Q01344-1
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human IL-5RA protein Asp21-Glu335 (Accession# Q01344-1) with a rabbit IgG Fc tag at the C-terminus. |
Predicted Molecular Mass | 65.1 kDa |
SDS-PAGE | 65-85 kDa, reducing (R) condition |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
IL-5RA, also known as the interleukin-5 receptor subunit alpha (CD125), is a crucial component of the interleukin-5 receptor complex, which plays a significant role in immune responses. IL-5RA is a specific subunit of a heterodimeric cytokine receptor that, along with the signal transducing beta subunit (IL-5RB), forms the complete IL-5 receptor complex. IL-5RA is primarily expressed on the surface of eosinophils and is responsible for the proliferation, differentiation, and activation of these cells. It is a key regulator in allergic reactions and asthma (PMID: 21986312; 28913336; 18511250).
References:
1. Takatsu K. et al. (2011). Proc Jpn Acad Ser B Phys Biol Sci. 87(8):463-485. 2. Bagnasco D. et al. (2017). Front Med (Lausanne). 4:135. 3. Takatsu K. et al. (2008). Curr Opin Immunol. 20(3):288-294.